An activating mutation in the <i>CSF3R</i> gene induces a hereditary chronic neutrophilia

Isabelle Plo(Inserm), Stéphane de Botton(Université Paris-Saclay)

The Journal of Experimental Medicine

July 20, 2009

10.1084/jem.20090693

Cited by 81

Related Papers

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

|Blood|2017|1.5k

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

|New England Journal of Medicine|2018|1.4k

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

|Blood|2002|503

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations

|Cancer Discovery|2017|457

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

|Leukemia|2006|355